Cleveland Clinic’s Director of Rare Cancers and Blood Diseases explains how having a formalized system in place for treating rare cancers can shorten the diagnostic odyssey and help improve patient outcomes and quality of life.
A Pandemic of Cancer Cases?
A sharp upswing in cancer diagnoses, harder-to-treat advanced cancers, and cancer deaths may be among the many unexpected consequences of the coronavirus pandemic, Cleveland Clinic Cancer Center oncologist Mikkael Sekeres, MD, warns in a new New York Times column.
Clinical Evaluation of IsoPSA, a Disease-Specific Biomarker for Prostate Cancer
Study suggests that novel prostate-specific antigen assay could significantly reduce unnecessary biopsies and help urologists provide men with the information needed to make informed decisions.
Innovative Strategies Being Used to Assess Cancer Patients for Distress
As routine psychosocial screening of oncology patients for distress becomes required for accreditation, Cleveland Clinic has developed a system that uses an EMR-integrated screening tool to assess all patients at check-in.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy